Eating Disorders Genetics Initiative 2
NCT06594913
This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .
Summary
The overarching intention of the Eating Disorder Genetics Initiative 2 (EDGI2) is to increase sample size, diversity, and eating disorder phenotypes. The investigators are enrolling 20,000 new participants with anorexia nervosa (AN), bulimia nervosa (BN), binge-eating disorder (BED), avoidant/restrictive food intake disorder (ARFID), and controls in the US, Mexico, Australia, New Zealand, Sweden, and Denmark. A primary study goal is to enroll at least 30% of participants from underrepresented groups.
Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov
Conditions studied
- Anorexia Nervosa
- Bulimia Nervosa
- Binge-Eating Disorder
- Avoidant Restrictive Food Intake Disorder
Eligibility basics and study details
- Study type
- Observational
- Phase
- Not applicable
- Ages
- 12 to 99 years
- Sex
- All
- Healthy volunteers
- Accepted
- Sponsor
- University of North Carolina, Chapel Hill
- Last updated on ClinicalTrials.gov
- July 8, 2026
These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.
US recruiting sites
North Carolina · 1
- University of North Carolina at Chapel Hill · Chapel Hill, NC
Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.